Treatment for Widal Test Positive Patients

Diagnostic Considerations

The Widal test is a serological test that detects agglutinating antibodies against O and H antigens of Salmonella Typhi and Paratyphi, and can be helpful in diagnosing typhoid fever when interpreted carefully, but has limitations in endemic areas 1
The Widal test lacks sensitivity and specificity, especially in endemic areas where background antibody levels may be elevated 1
Newer rapid serological tests detecting IgM against specific antigens have been developed but show mixed results 1
Blood cultures remain the gold standard for diagnosis, with highest yield within the first week of symptom onset 1

For non-resistant areas, the Centers for Disease Control and Prevention recommends oral chloroquine: Total dose of 1,500 mg (approximately 25 mg/kg body weight) over 3 days 2
For areas with fluoroquinolone resistance, the Journal of Infection suggests intravenous ceftriaxone is preferred as first-line agent, with a duration of 14 days to reduce risk of relapse 1
For uncomplicated cases with confirmed sensitivity, azithromycin is a suitable oral alternative for uncomplicated disease 1

Pregnant women should be treated aggressively using the adult regimen; chloroquine is safe during pregnancy 2
Children should receive a total dose of 25 mg/kg body weight over 3 days (10 mg/kg, 10 mg/kg, and 5 mg/kg at 0, 24, and 48 hours) 2

Patients who remain symptomatic longer than 3 days into therapy should have a repeat thick smear examined, and alternative therapy should be instituted if the degree of parasitemia has not diminished markedly by this time 2
For patients with severe disease, frequent monitoring of hemoglobin and platelet counts, electrolytes, and renal function is recommended 3

Gastrointestinal bleeding, intestinal perforation, and typhoid encephalopathy occur in 10-15% of patients, and are more likely if the duration of illness is >2 weeks 1
Addition of steroids may be helpful in severe cases 1

Vaccination provides incomplete protection against typhoid fever and does not protect from paratyphoid 1
In areas with increasing fluoroquinolone resistance, sensitivity testing is crucial; more than 70% of S. typhi and S. paratyphi isolates imported into the UK are resistant to fluoroquinolones 1

Bone marrow cultures have higher sensitivity than blood cultures 1
When testing isolates for antibiotic sensitivity, ciprofloxacin disc testing alone is unreliable; sensitivity to nalidixic acid should also be confirmed 1